Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Cristiano R, Jesse"'
Autor:
Cristiani F, Bortolatto, Angélica S, Reis, Mikaela P, Pinz, Guilherme T, Voss, Renata L, Oliveira, Ane G, Vogt, Silvane, Roman, Cristiano R, Jesse, Cristiane, Luchese, Ethel A, Wilhelm
Publikováno v:
Metabolic brain disease. 32(6)
The aim of the present study was to investigate the effects of SCH58261, a selective adenosine A
Autor:
Fernanda D, da Silva, Mikaela P, Pinz, Renata L, de Oliveira, Karline C, Rodrigues, Francine R, Ianiski, Mariana M, Bassaco, Claudio C, Silveira, Cristiano R, Jesse, Silvane S, Roman, Ethel A, Wilhelm, Cristiane, Luchese
Publikováno v:
Metabolic brain disease. 32(6)
The present study investigated the possible effect of BMMS in protecting against memory impairment in an Alzheimer's disease model induced by scopolamine in mice. Another objective was to evaluate the involvement of oxidative stress and Na
Autor:
Leandro Cattelan, Souza, Cristiano R, Jesse, Lucian, Del Fabbro, Marcelo Gomes, de Gomes, Nathalie Savedra, Gomes, Carlos Borges, Filho, André Tiago Rossito, Goes, Ethel Antunes, Wilhelm, Cristiane, Luchese, Silvane Souza, Roman, Silvana Peterini, Boeira
Publikováno v:
Molecular and cellular neurosciences. 88
An increasing body of evidence indicates that the activation of indoleamine-2,3-dyoxigenase (IDO), a first and rate-limiting enzyme in the kynurenine (KYN) pathway, is involved in Aβ
Autor:
Leandro Cattelan, Souza, Cristiano R, Jesse, Lucian, Del Fabbro, Marcelo Gomes, de Gomes, André Tiago Rossito, Goes, Carlos Borges, Filho, Cristiane, Luchese, Albanin Aparecida Mielniczki, Pereira, Silvana Peterini, Boeira
Publikováno v:
Behavioural brain research. 331
Emerging evidence indicates that the activation of indoleamine-2,3-dioxygenase (IDO), a first and rate-limiting enzyme in the kynurenine (KYN) pathway, is involved in amyloid-beta (Aβ
Autor:
Leandro C, Souza, Carlos B, Filho, André T R, Goes, Lucian Del, Fabbro, Marcelo G, de Gomes, Lucielli, Savegnago, Mauro Schneider, Oliveira, Cristiano R, Jesse
Publikováno v:
Neurotoxicity research. 24(2)
This study was designed to investigate the potential neuroprotective effect of exercise in a mouse model of Alzheimer's disease (AD) induced by intracerebroventricular (i.c.v.) injection of beta-amyloid₁₋₄₀ (Aβ₁₋₄₀) peptide. For this
Autor:
Carlos Borges, Filho, Lucian, Del Fabbro, Silvana P, Boeira, Ana Flávia, Furian, Lucielli, Savegnago, Letiére Cabreira, Soares, Antonio Luiz, Braga, Cristiano R, Jesse
Publikováno v:
Cell biochemistry and function. 31(2)
From a pharmacological point of view, organoseleniums are compounds with important and interesting antioxidant and biological activities. The aim of this study was to evaluate the hepatoprotective effect of bis(4-methylbenzoyl) diselenide (BMD) again
Autor:
Cristiano R, Jesse, Cristiani F, Bortolatto, Ethel A, Wilhelm, Silvane Souza, Roman, Marina, Prigol, Cristina W, Nogueira
Publikováno v:
Journal of applied toxicology : JAT. 34(1)
Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists not only improve metabolic abnormalities of diabetes and consequent diabetic nephropathy, but they also protect against non-diabetic kidney disease in experimental models. Here, we inve
Publikováno v:
Fundamentalclinical pharmacology. 26(4)
The aim of this study was to investigate the effect of SCH 58261, a selective adenosine A(2A) receptor (A(2A)R) antagonist, on kainic acid (KA)-induced seizures in 21-day-old rats. Rats were pretreated with SCH 58261 (1 or 3 mg/kg) by intraperitoneal
Publikováno v:
Fundamentalclinical pharmacology. 25(1)
The in vitro effect of (E)-2-benzylidene-4-phenyl-1,3-diselenole (BPD) was evaluated through iron/EDTA-induced thiobarbituric acid reactive species (TBARS) and reactive species (RS) determinations as well as of the scavenging 2,2'-diphenyl-1-picrylhy
Mechanisms involved in the antinociceptive effect caused by diphenyl diselenide in the formalin test
Autor:
Lucielli, Savegnago, Cristiano R, Jesse, Adair R S, Santos, Joâo B T, Rocha, Cristina W, Nogueira
Publikováno v:
The Journal of pharmacy and pharmacology. 60(12)
This study investigated the mechanisms involved in the antinociceptive action induced by diphenyl diselenide ((PhSe)(2)) in the formalin test. Mice were pre-treated with (PhSe)(2) by the oral route (0.1-100 mg kg(-1)), 30 min before formalin injectio